Related references
Note: Only part of the references are listed.Increased Global Functional Connectivity Correlates with LSD-Induced Ego Dissolution
Enzo Tagliazucchi et al.
CURRENT BIOLOGY (2016)
LSD modulates music-induced imagery via changes in parahippocampal connectivity
Mendel Kaelen et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2016)
Ego-Dissolution and Psychedelics: Validation of the Ego-Dissolution Inventory (EDI)
Matthew M. Nour et al.
FRONTIERS IN HUMAN NEUROSCIENCE (2016)
LSD-Induced Entropic Brain Activity Predicts Subsequent Personality Change
A. V. Lebedev et al.
HUMAN BRAIN MAPPING (2016)
Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences
Theresa M. Carbonaro et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2016)
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial
Roland R. Griffiths et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2016)
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial
Stephen Ross et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2016)
Effects of serotonin 2A/1A receptor stimulation on social exclusion processing
Katrin H. Preller et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
The paradoxical psychological effects of lysergic acid diethylamide (LSD)
R. L. Carhart-Harris et al.
PSYCHOLOGICAL MEDICINE (2016)
Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study
Robin L. Carhart-Harris et al.
LANCET PSYCHIATRY (2016)
Recent advances in the neuropsychopharmacology of serotonergic hallucinogens
Adam L. Halberstadt
BEHAVIOURAL BRAIN RESEARCH (2015)
Acute Effects of Lysergic Acid Diethylamide in Healthy Subjects
Yasmin Schmid et al.
BIOLOGICAL PSYCHIATRY (2015)
Psilocybin-Induced Decrease in Amygdala Reactivity Correlates with Enhanced Positive Mood in Healthy Volunteers
Rainer Kraehenmann et al.
BIOLOGICAL PSYCHIATRY (2015)
Classic psychedelic use is associated with reduced psychological distress and suicidality in the United States adult population
Peter S. Hendricks et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2015)
Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin
Frederick S. Barrett et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2015)
Psychedelics not linked to mental health problems or suicidal behavior: A population study
Pal-Orjan Johansen et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2015)
Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study
Michael P. Bogenschutz et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2015)
Psilocybin-induced spiritual experiences and insightfulness are associated with synchronization of neuronal oscillations
Michael Kometer et al.
PSYCHOPHARMACOLOGY (2015)
LSD enhances the emotional response to music
M. Kaelen et al.
PSYCHOPHARMACOLOGY (2015)
The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs
Robin L. Carhart-Harris et al.
FRONTIERS IN HUMAN NEUROSCIENCE (2014)
Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction
Matthew W. Johnson et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2014)
Implications for psychedelic-assisted psychotherapy: functional magnetic resonance imaging study with psilocybin
R. L. Carhart-Harris et al.
BRITISH JOURNAL OF PSYCHIATRY (2012)
Prediction of Psilocybin Response in Healthy Volunteers
Erich Studerus et al.
PLOS ONE (2012)
Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer
Charles S. Grob et al.
ARCHIVES OF GENERAL PSYCHIATRY (2011)
Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies
Erich Studerus et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2011)
Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness
Katherine A. MacLean et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2011)
Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects
Roland R. Griffiths et al.
PSYCHOPHARMACOLOGY (2011)
Psychometric Evaluation of the Altered States of Consciousness Rating Scale (OAV)
Erich Studerus et al.
PLOS ONE (2010)
Human hallucinogen research: guidelines for safety
M. W. Johnson et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2008)
Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later
R. R. Griffiths et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2008)
The effects of the preferential 5-HT2A agonist psilocybin on prepulse inhibition of startle in healthy human volunteers depend on interstimulus interval
Franz X. Vollenweider et al.
NEUROPSYCHOPHARMACOLOGY (2007)
Sensitivity of goodness of fit indexes to lack of measurement invariance
Fang Fang Chen
STRUCTURAL EQUATION MODELING-A MULTIDISCIPLINARY JOURNAL (2007)
Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance
R. R. Griffiths et al.
PSYCHOPHARMACOLOGY (2006)
Psychological effects of (S)-ketamine and N,N-dimethyltryptamine (DMT): A double-blind, cross-over study in healthy volunteers
E Gouzoulis-Mayfrank et al.
PHARMACOPSYCHIATRY (2005)
Altered consciousness in flotation-REST and chamber-REST: Experience of experimental pain and subjective stress
A Kjellgren et al.
SOCIAL BEHAVIOR AND PERSONALITY (2004)
Subjective effects and tolerability of the South American psychoactive beverage Ayahuasca in healthy volunteers
J Riba et al.
PSYCHOPHARMACOLOGY (2001)
Share Paper
